Converse P, Almeida D, Nuermberger E
Methods Mol Biol. 2021; 2387:195-207.
PMID: 34643914
PMC: 8996816.
DOI: 10.1007/978-1-0716-1779-3_19.
Leal-Calvo T, Martins B, Bertoluci D, Rosa P, Camargo R, Germano G
Front Immunol. 2021; 12:647832.
PMID: 33936067
PMC: 8085500.
DOI: 10.3389/fimmu.2021.647832.
van der Werf T, Barogui Y, Converse P, Phillips R, Stienstra Y
Expert Rev Clin Pharmacol. 2020; 13(4):391-401.
PMID: 32310683
PMC: 9020253.
DOI: 10.1080/17512433.2020.1752663.
Kim H, Fukutomi Y, Nakajima C, Kim Y, Mori S, Shibayama K
Sci Rep. 2019; 9(1):10815.
PMID: 31346236
PMC: 6658535.
DOI: 10.1038/s41598-019-47364-5.
Duthie M, Balagon M
Risk Manag Healthc Policy. 2016; 9:43-53.
PMID: 27175099
PMC: 4854245.
DOI: 10.2147/RMHP.S76058.
Phenotypic, molecular and antimicrobial susceptibility assessment in isolates from chronic ulcers of cured leprosy patients: a case study in Southern Brazil.
Gelatti L, Bonamigo R, Becker A, Eidt L, Ganassini L, d Azevedo P
An Bras Dermatol. 2014; 89(3):404-8.
PMID: 24937812
PMC: 4056696.
DOI: 10.1590/abd1806-4841.20142688.
Leprosy: an overview of pathophysiology.
Bhat R, Prakash C
Interdiscip Perspect Infect Dis. 2012; 2012:181089.
PMID: 22988457
PMC: 3440852.
DOI: 10.1155/2012/181089.
Leprosy and the human genome.
Misch E, Berrington W, Vary Jr J, Hawn T
Microbiol Mol Biol Rev. 2010; 74(4):589-620.
PMID: 21119019
PMC: 3008172.
DOI: 10.1128/MMBR.00025-10.
Experimental Leprosy.
Br Med J. 2010; 1(5337):1040-1.
PMID: 20789752
PMC: 2122934.
THE EXPERIMENTAL DISEASE THAT FOLLOWS THE INJECTION OF HUMAN LEPROSY BACILLI INTO FOOT-PADS OF MICE.
SHEPARD C
J Exp Med. 2009; 112(3):445-54.
PMID: 19867175
PMC: 2137235.
DOI: 10.1084/jem.112.3.445.
Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
Matrat S, Petrella S, Cambau E, Sougakoff W, Jarlier V, Aubry A
Antimicrob Agents Chemother. 2007; 51(5):1643-8.
PMID: 17325221
PMC: 1855561.
DOI: 10.1128/AAC.01282-06.
Hereditary Characteristic that Varies Among Isolates of Mycobacterium leprae.
SHEPARD C, McRae D
Infect Immun. 1971; 3(1):121-6.
PMID: 16557927
PMC: 416116.
DOI: 10.1128/iai.3.1.121-126.1971.
MYCOBACTERIAL DISEASE IN MAN AND ANIMALS. STUDIES ON LEPROSY BACILLI IN MAN AND ANIMALS.
Rees R
Proc R Soc Med. 1964; 57:482-3.
PMID: 14190866
PMC: 1898066.
SURVEY OF RECENT LEPROSY RESEARCH.
KIRCHHEIMER W
Public Health Rep (1896). 1964; 79:481-7.
PMID: 14155844
PMC: 1915449.
LIMITED MULTIPLICATION OF ACID-FAST BACILLI IN THE FOOT-PADS OF MICE INOCULATED WITH MYCOBACTERIUM LEPRAE.
Rees R
Br J Exp Pathol. 1964; 45:207-18.
PMID: 14140757
PMC: 2093071.
Viability of Mycobacterium leprae after multiplication in mice.
Welch T, GELBER R, MURRAY L, Ng H, ONeill S, Levy L
Infect Immun. 1980; 30(2):325-8.
PMID: 7002795
PMC: 551313.
DOI: 10.1128/iai.30.2.325-328.1980.
The six disease of WHO.
Waters M
Br Med J (Clin Res Ed). 1981; 283(6302):1320-2.
PMID: 6794841
PMC: 1507675.
DOI: 10.1136/bmj.283.6302.1320.
Experimental infection of the ear and foot pad of the golden hamster with Mycobacterium leprae.
Waters M, Niven J
Br J Exp Pathol. 1966; 47(1):86-92.
PMID: 5325423
PMC: 2094594.
The first decade in experimental leprosy.
SHEPARD C
Bull World Health Organ. 1971; 44(6):821-7.
PMID: 4950564
PMC: 2427880.
New prospects for the study of leprosy in the laboratory.
Rees R
Bull World Health Organ. 1969; 40(5):785-800.
PMID: 4898388
PMC: 2554501.
